By Rogier van Vlissingen : As I am writing this on the morning of the 4th of July, the latest analyst recommendations on Herbalife ( HLF ) reported on Nasdaq are 4 "strong buys" and one "hold," which is a really bizarre picture in a scenario where a not so minor activist investor, in the person of
By Rogier van Vlissingen : Herbalife ( HLF ) is not alone, and while the current investigations may turn up issues that are unique to Herbalife, the company seems destined to be the poster child for what is wrong with the MLM "industry." After three decades of uncontrolled growth, based, at least
By Rogier van Vlissingen : Herbalife ( HLF ) excelled once more in PR spin and the art of newspeak, called the ruling of the 9th circuit court " supportive ." For a reliable Reader's Digest version of the ruling and its meaning, Prof. William Keep is the go to, here . BurnLounge had argued that ...
Graham. I found about 20 firms that make the grade; here’s a look at some of the best of the bunch. USANA Health Sciences ( USNA ) : Utah-based USANA ($440 million market cap) makes nutritional and personal care products that it sells
Steve Alexander submits: The Magic Formula Investing (MFI) strategy is a ranking system. Any particular universe of stocks can be ranked in the strategy's fashion - a composite of highest earnings yield and highest adjusted return on capital , both factors equally weighted. You can apply the ...
We are no longer providing equity research on Usana Health Sciences USNA . We provide broad coverage of more than 1,800 companies across 91 industry groups and adjust our coverage as necessary based on client demand and investor interest.
Usana Health Sciences ' USNA first-quarter results came in about where we expected, and we don't expect to alter our fair value estimate. Sales fell 4
On Monday, Usana Health Sciences USNA announced fourth-quarter and full-year earnings that were essentially in line with management's lowered guidance. Fourth
On Thursday, Usana Health Sciences USNA preannounced fourth-quarter and full-year 2008 earnings. Although the firm underperformed relative to management's forecast
We've lowered our fair value uncertainty rating for Usana Health Sciences USNA to very high from extreme. While we still have some deep reservations about the management of this firm (above and beyond the